Logo image of CHR

CHEER HOLDING INC-A (CHR) Stock Fundamental Analysis

USA - NASDAQ:CHR - KYG399732042 - Common Stock

0.124 USD
0 (-0.08%)
Last: 10/20/2025, 10:50:02 AM
Fundamental Rating

4

Taking everything into account, CHR scores 4 out of 10 in our fundamental rating. CHR was compared to 70 industry peers in the Interactive Media & Services industry. CHR has only an average score on both its financial health and profitability. CHR does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

6

1. Profitability

1.1 Basic Checks

In the past year CHR was profitable.
In the past year CHR had a positive cash flow from operations.
Each year in the past 5 years CHR has been profitable.
CHR had a positive operating cash flow in each of the past 5 years.
CHR Yearly Net Income VS EBIT VS OCF VS FCFCHR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 10M 20M 30M 40M

1.2 Ratios

With a decent Return On Assets value of 7.49%, CHR is doing good in the industry, outperforming 80.00% of the companies in the same industry.
The Return On Equity of CHR (8.51%) is better than 75.71% of its industry peers.
Looking at the Return On Invested Capital, with a value of 6.59%, CHR is in the better half of the industry, outperforming 75.71% of the companies in the same industry.
CHR had an Average Return On Invested Capital over the past 3 years of 9.00%. This is below the industry average of 13.27%.
Industry RankSector Rank
ROA 7.49%
ROE 8.51%
ROIC 6.59%
ROA(3y)9.95%
ROA(5y)13.67%
ROE(3y)11.67%
ROE(5y)17.03%
ROIC(3y)9%
ROIC(5y)13.46%
CHR Yearly ROA, ROE, ROICCHR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 5 10 15 20 25

1.3 Margins

With an excellent Profit Margin value of 17.64%, CHR belongs to the best of the industry, outperforming 84.29% of the companies in the same industry.
In the last couple of years the Profit Margin of CHR has declined.
CHR has a Operating Margin of 17.39%. This is amongst the best in the industry. CHR outperforms 84.29% of its industry peers.
CHR's Operating Margin has declined in the last couple of years.
CHR has a Gross Margin of 73.24%. This is in the better half of the industry: CHR outperforms 65.71% of its industry peers.
In the last couple of years the Gross Margin of CHR has declined.
Industry RankSector Rank
OM 17.39%
PM (TTM) 17.64%
GM 73.24%
OM growth 3Y-9.83%
OM growth 5YN/A
PM growth 3Y-8.55%
PM growth 5YN/A
GM growth 3Y-1.72%
GM growth 5YN/A
CHR Yearly Profit, Operating, Gross MarginsCHR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 20 40 60

More info and screens

6

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so CHR is still creating some value.
The number of shares outstanding for CHR has been increased compared to 1 year ago.
CHR has less shares outstanding than it did 5 years ago.
CHR has a worse debt/assets ratio than last year.
CHR Yearly Shares OutstandingCHR Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
CHR Yearly Total Debt VS Total AssetsCHR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

CHR has an Altman-Z score of 2.47. This is not the best score and indicates that CHR is in the grey zone with still only limited risk for bankruptcy at the moment.
The Altman-Z score of CHR (2.47) is better than 67.14% of its industry peers.
A Debt/Equity ratio of 0.00 indicates that CHR is not too dependend on debt financing.
With a decent Debt to Equity ratio value of 0.00, CHR is doing good in the industry, outperforming 67.14% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 2.47
ROIC/WACC1.07
WACC6.14%
CHR Yearly LT Debt VS Equity VS FCFCHR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M

2.3 Liquidity

A Current Ratio of 7.66 indicates that CHR has no problem at all paying its short term obligations.
With an excellent Current ratio value of 7.66, CHR belongs to the best of the industry, outperforming 88.57% of the companies in the same industry.
CHR has a Quick Ratio of 7.66. This indicates that CHR is financially healthy and has no problem in meeting its short term obligations.
CHR has a better Quick ratio (7.66) than 88.57% of its industry peers.
Industry RankSector Rank
Current Ratio 7.66
Quick Ratio 7.66
CHR Yearly Current Assets VS Current LiabilitesCHR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

More info and screens

1

3. Growth

3.1 Past

CHR shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -33.05%.
Measured over the past years, CHR shows a very strong growth in Earnings Per Share. The EPS has been growing by 90.58% on average per year.
The Revenue has decreased by -5.65% in the past year.
CHR shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -1.28% yearly.
EPS 1Y (TTM)-33.05%
EPS 3Y-22.48%
EPS 5Y90.58%
EPS Q2Q%-15.99%
Revenue 1Y (TTM)-5.65%
Revenue growth 3Y-1.28%
Revenue growth 5YN/A
Sales Q2Q%-0.09%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CHR Yearly Revenue VS EstimatesCHR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 50M 100M 150M

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 0.05 indicates a rather cheap valuation of CHR.
100.00% of the companies in the same industry are more expensive than CHR, based on the Price/Earnings ratio.
When comparing the Price/Earnings ratio of CHR to the average of the S&P500 Index (27.42), we can say CHR is valued rather cheaply.
Industry RankSector Rank
PE 0.05
Fwd PE N/A
CHR Price Earnings VS Forward Price EarningsCHR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA -6.24
CHR Per share dataCHR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8 10

4.3 Compensation for Growth

The decent profitability rating of CHR may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for CHR!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CHEER HOLDING INC-A

NASDAQ:CHR (10/20/2025, 10:50:02 AM)

0.124

0 (-0.08%)

Chartmill FA Rating
GICS IndustryGroupMedia & Entertainment
GICS IndustryInteractive Media & Services
Earnings (Last)07-30 2025-07-30
Earnings (Next)03-09 2026-03-09
Inst Owners19.93%
Inst Owner ChangeN/A
Ins Owners0.66%
Ins Owner ChangeN/A
Market Cap3.02M
Analysts80
Price TargetN/A
Short Float %4.55%
Short Ratio0.87
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 0.05
Fwd PE N/A
P/S 0.02
P/FCF N/A
P/OCF 0.13
P/B 0.01
P/tB 0.01
EV/EBITDA -6.24
EPS(TTM)2.32
EY1870.97%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.08
FCFYN/A
OCF(TTM)0.94
OCFY758.54%
SpS6.05
BVpS12.54
TBVpS10.87
PEG (NY)N/A
PEG (5Y)0
Profitability
Industry RankSector Rank
ROA 7.49%
ROE 8.51%
ROCE 8.34%
ROIC 6.59%
ROICexc 18.54%
ROICexgc 29.52%
OM 17.39%
PM (TTM) 17.64%
GM 73.24%
FCFM N/A
ROA(3y)9.95%
ROA(5y)13.67%
ROE(3y)11.67%
ROE(5y)17.03%
ROIC(3y)9%
ROIC(5y)13.46%
ROICexc(3y)21.89%
ROICexc(5y)25.49%
ROICexgc(3y)29.91%
ROICexgc(5y)33.2%
ROCE(3y)11.4%
ROCE(5y)17.04%
ROICexcg growth 3Y-11.82%
ROICexcg growth 5YN/A
ROICexc growth 3Y-18.62%
ROICexc growth 5YN/A
OM growth 3Y-9.83%
OM growth 5YN/A
PM growth 3Y-8.55%
PM growth 5YN/A
GM growth 3Y-1.72%
GM growth 5YN/A
F-Score4
Asset Turnover0.42
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA 0.05
Cap/Depr 650.5%
Cap/Sales 16.89%
Interest Coverage 78.74
Cash Conversion 77.77%
Profit Quality N/A
Current Ratio 7.66
Quick Ratio 7.66
Altman-Z 2.47
F-Score4
WACC6.14%
ROIC/WACC1.07
Cap/Depr(3y)296.64%
Cap/Depr(5y)223.79%
Cap/Sales(3y)7.33%
Cap/Sales(5y)5.21%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-33.05%
EPS 3Y-22.48%
EPS 5Y90.58%
EPS Q2Q%-15.99%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-5.65%
Revenue growth 3Y-1.28%
Revenue growth 5YN/A
Sales Q2Q%-0.09%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-12.6%
EBIT growth 3Y-10.99%
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-104.71%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-45.76%
OCF growth 3Y-21.03%
OCF growth 5YN/A